VYVGART (efgartigimod alfa-fcab) injection
VYVGART is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive. FDA approved efgartigimod alfa-fcab (brand name VYVGART) is not (yet) registered or available in India. The access to the drug is provided as per Name Patient Program respecting the regulatory framework as desired by local authorities.
Home | efgartigimod alfa-fcab injection
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
VYVGART (efgartigimod alfa-fcab) injection
Efgartigimod alfa, is a medication used to treat myasthenia gravis. Efgartigimod alfa is a neonatal Fc receptor blocker and is a new class of medication.
VYVGART is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive
Efgartigimod alfa, sold under the brand name Vyvgart, is a medication used to treat myasthenia gravis. Efgartigimod alfa is a neonatal Fc receptor blocker and is a new class of medication. It is an antibody fragment that binds to the neonatal Fc receptor (FcRn), preventing FcRn from recycling immunoglobulin G (IgG) back into the blood. The medication causes a reduction in overall levels of IgG, including the abnormal acetylcholine receptor (AChR) antibodies that are present in myasthenia gravis. It is also available coformulated with hyaluronidase.
The most common side effects include respiratory tract infections, headache, urinary tract infections, and paresthesia (numbness, tingling)
Drug (Brand / Generic): VYVGART ™ (efgartigimod alfa-fcab) injection, for intravenous use Initial U.S. Approval: 2021
Current Indication: generalized myasthenia gravis (gMG)
Approval Date: 2021
Injection: 400 mg in 20 mL (20 mg/mL) single-dose vial.
Find Reference Updates
- VYVGART (efgartigimod alfa-fcab) injection Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions.
- FDA approves treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults
- argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
- FDA grants priority review for expanded Vyvgart use in gMG
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is a trusted pharmaceutical access facilitator in India, aligned with Good Distribution Practice (GDP) standards. We provide specialized support to help patients and healthcare professionals access VYVGART (efgartigimod alfa-fcab) injection, an internationally approved therapy.
Where VYVGART is not commercially available in India, we facilitate access through regulated pathways such as the Named Patient Supply (NPS) framework. Each request is carefully managed in compliance with applicable regulations and requires a valid prescription and, where necessary, import authorization.
Get Access to FDA approved efgartigimod alfa-fcab (brand name VYVGART) in India.
We can help patients access approved VYVGART (efgartigimod alfa-fcab) injection in the following cities across India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
VYVGART (efgartigimod alfa-fcab) injection – Sourcing & Access Support
Alleviare India provides assistance in facilitating access to VYVGART (efgartigimod alfa-fcab) injection, a prescribed oncology medication, through trusted international supply channels. We support patients and healthcare providers in identifying appropriate supply options for medicines that may have limited local availability, in accordance with applicable regulations.Access is provided only against a valid prescription, and services are offered under the Named Patient Supply (NPS) framework. Alleviare India may also assist in connecting with authorized supply channels where appropriate.Pricing & Availability in India
For information on the availability and indicative pricing of VYVGART (efgartigimod alfa-fcab) injection, please contact us directly.The cost of the medicine is determined by the manufacturer. Additional charges may include Named Patient support service fees, shipping costs, and applicable local taxes, in accordance with regulatory requirements.Is VYVGART available in India?
Meet Our Medicine Access Expert for availability of Truqap medications.At Alleviare, we prioritize transparency while supporting patients, healthcare professionals, and institutions in accessing genuine medicines through trusted global sources in Canada, Europe, the USA, and Australia. We provide tailored assistance to facilitate access to prescribed therapies, including those not readily available locally, in full compliance with applicable regulatory requirements.Access is facilitated under the Named Patient Supply (NPS) framework. We also offer guidance on the availability and indicative pricing of prescribed medications across major cities in India, including Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune.Medicine: VYVGART (efgartigimod alfa-fcab) injection (subject to prescription and regulatory guidelines)Start Your Access JourneyEmail: info@alleviareindia.com, Mobile: +91 9818274099 / 9289711088Is efgartigimod alfa-fcab available in India?Yes, FDA approved efgartigimod alfa-fcab (brand name VYVGART) is not (yet) registered or available in India but on request Indian patient can buy VYVGART at the lowest price.What documents are required to import VYVGART to India?
To import VYVGART (efgartigimod alfa-fcab), patients or government hospitals can place an order on behalf of the patients. The following documentation is required for the import process:- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
- Valid prescription from the doctor.
- Import permit, if applicable.